GK-11: a Novel Cationic Peptide with Antibiofilm Activity against Staphylococcus aureus and Pseudomonas aeruginosa


Creative Commons License

Aldağ S., Buğdacı G. T., Çobanoğlu Ş., Erkengez E., Arslan M. E., Kadı A., ...Daha Fazla

Probiotics and Antimicrobial Proteins, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1007/s12602-026-10963-6
  • Dergi Adı: Probiotics and Antimicrobial Proteins
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Anahtar Kelimeler: Antibiofilm peptide, Caenorhabditis elegans, GK-11, Pseudomonas aeruginosa, Staphylococcus aureus
  • Atatürk Üniversitesi Adresli: Evet

Özet

Biofilms are implicated in most chronic infections and exhibit up to 1000-fold higher antibiotic resistance than planktonic cells, creating an urgent need for new antibiofilm agents. Here, we characterized GK-11, an 11-amino acid derivative of pleurocidin. Although GK-11 showed limited antimicrobial activity (MIC: 64 µg/mL for Staphylococcus aureus and 256 µg/mL for Pseudomonas aeruginosa), it demonstrated potent antibiofilm effects at sub-MIC levels (MBIC: 32 µg/mL and 16 µg/mL, respectively). Microscopy and SEM confirmed disruption of biofilm structure, while qRT-PCR revealed downregulation of key virulence genes. GK-11 was non-toxic to Caenorhabditis elegans and maintained > 80% viability in human fibroblasts. In vivo, GK-11 improved worm survival against MRSA and PAO1 infection. These results identify GK-11 as a promising, low-toxicity peptide with selective antibiofilm activity for potential therapeutic development.